Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia
Main Article Content
The behavior of the COVID-19 pandemic during the three peaks registered in Cali has been heterogeneous, and the severity of infections and deaths has varied over time. Cali, with 2.2 million inhabitants, is the third most populated city in Colombia; as of November 21, 2021, it has recorded 285 thousand confirmed cases and 7,474 deaths due to the infection. The vaccination plan against SARS-CoV-2, which was started in February, has immunized 1.54 million people in Cali.
As in the rest of the country, the development of the vaccination plan in Cali coincided with the third peak of the pandemic, the most lethal and prolonged; as well as with multiple social mobilizations of hundreds of protesters who crowded the streets, between May and June 2021, protesting against an unpopular tax reform enacted by the national government. In Cali, the vaccination plan was also affected by lack of access to health services and vaccination points due to blockages registered in different zones of the city. At the end of the third peak, the country faced difficulties in continuing with the vaccination plan due to barriers to accessing vaccines in the international market.
Departamento Administrativo Nacional de Estadística (DANE). Proyecciones de población 2018-2023. DANE; 2020. Cited: 2021 Nov 21. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion.
Secretaria de Salud Pública. COVID19_21noviembre. Boletín Epidemiológico No.622. Cali: Alcaldia de Santiago de Cali; 2021. Available from: https://www.cali.gov.co/salud/publicaciones/152840/boletines-epidemiologicos/.
Secretaria de Salud Pública. COVID19_23noviembre. Boletín Vacunación COVID No.265. Cali: Alcaldia de Santiago de Cali; 2021. Cited: 2021 Nov 21. Available from: https://www.cali.gov.co/salud/publicaciones/159073/boletines-vacunacion-covid/
Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med. 2021; 385: 875-884. https://doi.org/10.1056/NEJMoa2107715
Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, Meece J, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers - eight u.s. locations, December 2020-March . MMWR Morb Mortal Wkly Rep. 2021;70(13):495-500. https://doi.org/10.15585/mmwr.mm7013e3
Kai X, Xiao-Yan T, Miao L, Zhang-Wu L, Jiang-Nan C, Jiao-Jiao L, et al. Efficacy and safety of COVID-19 vaccines: A systematic review. Chinese J Contemp Pediatr. 2021; 23(3):221-8. https://10.7499/j.issn.1008-8830.2101133
Higdon MM, Wahl B, Jones CB, Rosen JG, Truelove SA, Baidya A, et al. A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease. medRxiv. 2021. https://doi.org/10.1101/2021.09.17.21263549
Goldman E. How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective. Proc Natl Acad Sci United States Am. 2021;118(39): e2114279118. https://doi.org/10.1073/pnas.2114279118
- Pablo A. Bravo, Sonia M. Bravo, Beatriz Porras, Jaime Valderrama, Angel Erazo, Luis Eduardo Bravo, Prevalencia de sustancias psicoactivas asociadas con muertes violentas en Cali. , Colombia Medica: Vol. 36 No. 3 (2005)
- Luis Eduardo Bravo, Luz Stella García, Paola Andrea Collazos, Cancer survival in Cali, Colombia: A population-based study, 1995-2004 , Colombia Medica: Vol. 45 No. 3 (2014)
- Andrés Fandiño-Losada, Rodrigo Guerrero, Is Colombia a violent country? , Colombia Medica: Vol. 48 No. 1 (2017)
- Consuelo de Rovetto, Andrés Felipe Ortiz, Ricardo Zarama, Luis Eduardo Bravo, Acalculous cholecystitis: complication of pediatric systemic lupus erythematosus. , Colombia Medica: Vol. 38 No. 1 Supl 1 (2007): Gastrología Pediátrica
- Luis Eduardo Bravo, Juliana Alexandra Hernández Vargas, Paola Collazos, Luz Stella García, Ana María Valbuena, Lizbeth Acuña, Survival in stomach cancer: analysis of a national cancer information system and a population-based cancer registry in Colombia , Colombia Medica: Vol. 53 No. 4 (2022): The death debate
- Clara I. Campos, Luis Eduardo Bravo, Los clínicos son de marte y los patólogos de venus. Interpretación clínica de los informes de patología. , Colombia Medica: Vol. 32 No. 4 (2001)
- Maria Clara Yepez, Luis Eduardo Bravo, Arsenio Hidalgo Troya, Daniel Marcelo Jurado, Luisa Mercedes Bravo, Cancer incidence and mortality in the municipality of Pasto, 1998 – 2007 , Colombia Medica: Vol. 43 No. 4 (2012): Numbers in cancer: 50-year of The Population-based Cancer Registry of Cali
- Luis Eduardo Bravo, Estimating the incidence and mortality of cancer in Colombia: What are the best data for public policies? , Colombia Medica: Vol. 47 No. 2 (2016)
- Rodrigo Guerrero, Pedro Rovetto, The teaching of medicine at Universidad del Valle , Colombia Medica: Vol. 41 No. 4 (2010)
- Rodrigo Rodriguez, Rodrigo Guerrero, Evaluación epidemiológica de las primeras jornadas nacionales de vacunación en Colombia, 1984 , Colombia Medica: Vol. 16 No. 3,4 (1985)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use